These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18515001)

  • 1. Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
    Morissette M; Al Sweidi S; Callier S; Di Paolo T
    Mol Cell Endocrinol; 2008 Aug; 290(1-2):60-9. PubMed ID: 18515001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    D'Astous M; Mendez P; Morissette M; Garcia-Segura LM; Di Paolo T
    Mol Pharmacol; 2006 Apr; 69(4):1492-8. PubMed ID: 16434614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective actions of sex steroids in Parkinson's disease.
    Bourque M; Dluzen DE; Di Paolo T
    Front Neuroendocrinol; 2009 Jul; 30(2):142-57. PubMed ID: 19410597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
    Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.
    Al Sweidi S; Sánchez MG; Bourque M; Morissette M; Dluzen D; Di Paolo T
    J Neuroendocrinol; 2012 Jan; 24(1):48-61. PubMed ID: 21790809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
    Bourque M; Dluzen DE; Di Paolo T
    Front Neuroendocrinol; 2012 Apr; 33(2):169-78. PubMed ID: 22387674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease.
    Baraka AM; Korish AA; Soliman GA; Kamal H
    Life Sci; 2011 May; 88(19-20):879-85. PubMed ID: 21420980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys.
    Morissette M; Di Paolo T
    J Neurosci Res; 2009 May; 87(7):1634-44. PubMed ID: 19115413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease.
    Litim N; Morissette M; Di Paolo T
    Neurosci Biobehav Rev; 2016 Aug; 67():79-88. PubMed ID: 26708712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
    Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
    Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease.
    Bezard E; Gerlach I; Moratalla R; Gross CE; Jork R
    Neurobiol Dis; 2006 Jul; 23(1):77-86. PubMed ID: 16545572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.
    Gillies GE; McArthur S
    Horm Behav; 2010 Jan; 57(1):23-34. PubMed ID: 19538962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease.
    Poirier AA; Côté M; Bourque M; Morissette M; Di Paolo T; Soulet D
    Neurobiol Aging; 2016 Dec; 48():61-71. PubMed ID: 27644075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?
    Morale MC; L'Episcopo F; Tirolo C; Giaquinta G; Caniglia S; Testa N; Arcieri P; Serra PA; Lupo G; Alberghina M; Harada N; Honda S; Panzica GC; Marchetti B
    Brain Res Rev; 2008 Mar; 57(2):431-43. PubMed ID: 18063054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates.
    Jakowec MW; Petzinger GM
    Comp Med; 2004 Oct; 54(5):497-513. PubMed ID: 15575363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.